Pretreatment biomarkers as prognostic predictors of survival in patients with Pancreatic Cancer treated with Gemcitabine-based Therapy and 5-Fluorouracil: Neutrophil-to-lymphocyte ratio vs Platelet-to-lymphocyte ratio.

In conclusion, pretreatment NLR is a promising independent outcome predictor for patients with PC, while NLR might not be a suitable factor in the selection of regimens for patients with PC. PMID: 32624701 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32624701?dopt=Abstract

Source: International Journal of Medical Sciences - July 7, 2020 Category: Biomedical Science Tags: Int J Med Sci Source Type: research